Please ensure Javascript is enabled for purposes of website accessibility

Gilead Sciences(GILD)

Nasdaq Global Select

GILD
Gilead Sciences Stock Quote
$68.77 -$0.52 -0.8%
Price as of June 11, 2021, 4:00 p.m. ET View Interactive GILD Charts

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

Interactive Chart


News & Analysis: Gilead Sciences

The Fool has written over 1800 articles on Gilead Sciences.

All

Market Moves

Podcasts

Earnings